Jazz Pharmaceuticals (JAZZ) Proxy filing summary

Executive summary

• The annual general meeting (AGM) is scheduled for July 23, 2026, with several key proposals up for shareholder vote.

• Shareholders of record as of May 28, 2026, are eligible to vote at the AGM.

• Employees who are also shareholders are encouraged to participate in the voting process to ensure their shares are represented.

Voting matters and shareholder proposals

• The board and management recommend voting "FOR" all director nominees and the other five proposals presented at the AGM.

• Voting instructions were distributed via mail or electronically, with specific guidance for those using E*Trade services.

Board of directors and corporate governance

• The board has nominated directors for election at the AGM and supports their approval.